← back to search

Parham Sadeghipour

HM Hospitales · IR
Area of research
Cardiology and Cardiovascular Medicine · Internal Medicine
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes, COVID-19 Clinical Research Studies, and Cardiac Valve Diseases and Treatments.
h-index
21
citations
2,617
works
212
NIH funding
primary concept
Medicine
email

Recent publications

Reperfusion strategies for acute pulmonary embolism: Design and rationale of RECONNECT-PE—A living systematic review and meta-analysis
American Heart Journal 2026cited by 1position: middledoi
Fibrinolytic Therapy for Thromboembolic Diseases
Journal of the American College of Cardiology 2025cited by 3position: middledoi
Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports
Thrombosis Research 2025cited by 2position: middledoi
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
Nature Reviews Cardiology 2024cited by 18position: middledoi
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications
Seminars in Thrombosis and Hemostasis 2024cited by 16position: middledoi
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review
Seminars in Thrombosis and Hemostasis 2024cited by 15position: middledoi
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology 2023cited by 19position: middledoi
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial
Thrombosis and Haemostasis 2023cited by 8position: middledoi
Cross-cultural validity of the Pulmonary Embolism Quality of Life questionnaire in the quality of life survey after pulmonary embolism: A Persian-speaking cohort
Research and Practice in Thrombosis and Haemostasis 2023cited by 7position: lastdoi
Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day
Journal of Thrombosis and Haemostasis 2023cited by 7position: middledoi
Post-Pulmonary Embolism Impairment Six Months after Acute Pulmonary Embolism: A Prospective Registry
Vascular and Endovascular Surgery 2023cited by 6position: lastdoi
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
JAMA 2021cited by 652position: middledoi
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19
Journal of the American College of Cardiology 2021cited by 179position: middledoi
Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial
Thrombosis Research 2021cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Behnood Bikdeli · Harvard University5 papers (2021–2025)Stefano Barco · Johannes Gutenberg University Mainz4 papers (2021–2023)Hooman Bakhshandeh · Shaheed Rajaei Cardiovascular Medical and Research Center3 papers (2021–2023)Manuel Monréal · Centro de Investigación Biomédica en Red de Enfermedades Respiratorias2 papers (2023–2024) · 2 papers (2023–2023) · 2 papers (2023–2023) · 2 papers (2023–2023)Azita H. Talasaz · Columbia University Irving Medical Center2 papers (2024–2025)Iréne Lang · University of Tübingen2 papers (2024–2025)Michelle L. O’Donoghue · Harvard University2 papers (2024–2025) · 2 papers (2023–2023)Harlan M. Krumholz · Yale University2 papers (2024–2025)David Jiménez · Universidad de Alcalá2 papers (2023–2024) · 2 papers (2023–2023)Eugene Braunwald · Brigham and Women's Hospital2 papers (2024–2025) · 2 papers (2023–2023)Christopher D. Anderson · Hesco (United States)2 papers (2024–2025) · 2 papers (2024–2025)Samuel Z. Goldhaber · Thrombolysis in Myocardial Infarction Study Group2 papers (2024–2025)Mitchell S.V. Elkind · Sage Colleges2 papers (2024–2025)